| Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors (NCT00333502) | NewLink Genetics Corporation | 2006-05-01 |
| Effect of Samarium on the Relief of Pain Due to Vertebral Metastases (NCT00374751) | New York Presbyterian Brooklyn Methodist Hospital | 2006-05-01 |
| Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma (NCT00396864) | Celgene | 2006-05-01 |
| Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma (NCT00588666) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports (NCT00921141) | Centre Oscar Lambret | 2006-05-01 |
| Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas (NCT00590954) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant (NCT00357084) | Fred Hutchinson Cancer Center | 2006-05-01 |
| Internet Support for Cancer Patients (NCT00710658) | Oslo University Hospital | 2006-05-01 |
| Study to Evaluate the Safety and Pharmacokinetics of SPI-1005 (NCT01452607) | Sound Pharmaceuticals, Incorporated | 2006-05-01 |
| The National Oncologic PET Registry (NCT00868582) | American College of Radiology Imaging Network | 2006-05-01 |
| Epidemiology of Venous Thromboembolism (NCT00456196) | Brigham and Women's Hospital | 2006-04-01 |
| A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer (NCT00326131) | Bristol-Myers Squibb | 2006-04-01 |
| Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer (NCT00363454) | Prescient Therapeutics, Ltd. | 2006-04-01 |
| Thai Cancer Anemia Survey in Chulalongkorn Hospital (NCT01018043) | Janssen-Cilag Ltd.,Thailand | 2006-04-01 |
| Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid (NCT00331045) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2006-04-01 |
| Psychological Interventions in Siblings of Children With Cancer (NCT00296907) | University Children's Hospital, Zurich | 2006-04-01 |
| Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma (NCT00322608) | Nereus Pharmaceuticals, Inc. | 2006-04-01 |
| Ixabepilone Administered as an Enteric Coated Formulation. (NCT00309049) | R-Pharm | 2006-04-01 |
| Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk Assess (NCT00822822) | H. Lee Moffitt Cancer Center and Research Institute | 2006-03-01 |
| A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy (NCT00597519) | Memorial Sloan Kettering Cancer Center | 2006-03-01 |
| Multi-Center Human Alert Trial to Prevent DVT and PE (NCT00409136) | Brigham and Women's Hospital | 2006-03-01 |
| A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy (NCT00306267) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-03-01 |
| Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) (NCT00308269) | Endocyte | 2006-03-01 |
| An Open Label Study of Oral Enzastaurin in Participants With Cancer (NCT00309140) | Eli Lilly and Company | 2006-03-01 |
| Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes (NCT00300001) | Community Cancer Care | 2006-03-01 |
| Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors (NCT00305084) | AGC Biologics S.p.A. | 2006-02-28 |
| Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma (NCT00310518) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2006-02-01 |
| Wormwood in Chronic Progressive Disorders With Reduced Appetite (NCT01126931) | University Hospital Freiburg | 2006-02-01 |
| Clinical Predictors of Survival in Cancer Patients With Metastatic Solid Tumors (NCT00322634) | New Mexico Cancer Research Alliance | 2006-02-01 |
| The Activity Intervention for Chemobrain (NCT00495703) | Vanderbilt University Medical Center | 2006-02-01 |
| Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015) (NCT00288431) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy (NCT00786383) | Eli Lilly and Company | 2006-02-01 |
| Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain (NCT00525967) | Faculdade de Medicina do ABC | 2006-02-01 |
| Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects (NCT00293033) | BioDelivery Sciences International | 2006-02-01 |
| Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy (NCT00293020) | BioDelivery Sciences International | 2006-02-01 |
| Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review (NCT00322725) | University of New Mexico | 2006-02-01 |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer (NCT00444054) | Albert Einstein College of Medicine | 2006-02-01 |
| Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer (NCT04198688) | Bispebjerg Hospital | 2006-01-03 |
| Modafinil in Opioid Induced Sedation (NCT00267332) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-01-01 |
| Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study (NCT00322790) | New Mexico Cancer Research Alliance | 2006-01-01 |
| Cancer Related Fatigue in Patients Receiving Chemotherapy (NCT00261534) | Medical Center Alkmaar | 2006-01-01 |
| Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15) (NCT06583161) | Harvard School of Public Health (HSPH) | 2006-01-01 |
| A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy (NCT01285219) | Chinese Academy of Medical Sciences | 2006-01-01 |
| ARQ 197 in Subjects With Metastatic Solid Tumors (NCT00302172) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2006-01-01 |
| Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy (NCT00272662) | Affymax | 2006-01-01 |
| RAW Study Version 3.4 (NCT00280722) | Oxford University Hospitals NHS Trust | 2006-01-01 |
| Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases (NCT00375830) | Stanford University | 2006-01-01 |
| Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors (NCT00259818) | Erimos Pharmaceuticals | 2005-12-01 |
| Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients (NCT00263575) | Kyowa Kirin Co., Ltd. | 2005-12-01 |
| Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients. (NCT00262678) | Kyowa Kirin Co., Ltd. | 2005-12-01 |
| Trial of Family Focused Grief Therapy in Palliative Care and Bereavement (NCT00580515) | Memorial Sloan Kettering Cancer Center | 2005-11-08 |
| Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy (NCT00285051) | Rafa Laboratories | 2005-11-01 |
| Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines (NCT02159482) | Duke University | 2005-11-01 |
| Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects (NCT00255138) | Temple University | 2005-11-01 |
| Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer (NCT00222729) | University of Pittsburgh | 2005-11-01 |
| Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors (NCT00246818) | National Center for Complementary and Integrative Health (NCCIH) | 2005-10-26 |
| Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma (NCT00311558) | The Cleveland Clinic | 2005-10-01 |
| Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer (NCT00226239) | University of Pittsburgh | 2005-10-01 |
| A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma (NCT00283439) | Amgen | 2005-10-01 |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer (NCT00274885) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2005-10-01 |
| Effect of Ketoconazole on the Pharmacokinetics of Vinflunine (NCT00388557) | Bristol-Myers Squibb | 2005-10-01 |
| Does Acupressure Help Reduce Nausea and Vomiting in Palliative Care Patients? (NCT00220688) | Gloucestershire Hospitals NHS Foundation Trust | 2005-09-01 |
| Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies (NCT00215605) | Exelixis | 2005-09-01 |
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer (NCT00329368) | Endocyte | 2005-09-01 |
| A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors (NCT00588107) | Dana-Farber Cancer Institute | 2005-09-01 |
| Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection (NCT00588341) | Memorial Sloan Kettering Cancer Center | 2005-09-01 |
| Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma (NCT00707278) | University of Utah | 2005-09-01 |
| Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants (NCT00899496) | Wake Forest University Health Sciences | 2005-09-01 |
| Implementation and Evaluation of Dignity Therapy in Denmark (NCT01507571) | Bispebjerg Hospital | 2005-09-01 |
| Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma (NCT00707161) | University of Utah | 2005-09-01 |
| Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage (NCT00248443) | Assistance Publique - Hôpitaux de Paris | 2005-08-01 |
| PRelationship Between Physical Activity and Cancer Ris (NCT00521651) | National Cancer Institute (NCI) | 2005-08-01 |
| Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer (NCT00387153) | Myriad Therapeutics, Inc. | 2005-08-01 |
| Safety Study to Evaluate FluMist in Immunocompromised Children (NCT00112112) | MedImmune LLC | 2005-08-01 |
| Effects of Oncological Treatment During Pregnancy on Mother and Child (NCT00330447) | University Hospital, Gasthuisberg | 2005-08-01 |
| Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer. (NCT00251563) | Nanjing Medical University | 2005-08-01 |
| Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies (NCT00239239) | Amgen | 2005-08-01 |
| Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy (NCT00144131) | Amgen | 2005-08-01 |
| Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors (NCT00110357) | Eli Lilly and Company | 2005-08-01 |
| Study of XL820 in Adults With Solid Tumors (NCT00129571) | Exelixis | 2005-08-01 |
| Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain (NCT00126789) | ZARS Pharma Inc. | 2005-08-01 |
| Reduced Intensity Transplant Using Extracorporeal Photopheresis (NCT00179790) | Ann & Robert H Lurie Children's Hospital of Chicago | 2005-07-01 |
| Acetaminophen for Cancer Pain (NCT00152854) | University Health Network, Toronto | 2005-07-01 |
| Resveratrol for Patients With Colon Cancer (NCT00256334) | University of California, Irvine | 2005-07-01 |
| Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer (NCT00981903) | University of Southern California | 2005-07-01 |
| Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) (NCT00311896) | Clinica Universidad de Navarra, Universidad de Navarra | 2005-07-01 |
| Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study (NCT00116090) | National Eye Institute (NEI) | 2005-06-16 |
| Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy (NCT00366717) | Mackay Memorial Hospital | 2005-06-01 |
| Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population (NCT00615147) | Memorial Sloan Kettering Cancer Center | 2005-05-01 |
| A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED) (NCT00104364) | Merck Sharp & Dohme LLC | 2005-05-01 |
| Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study (NCT00793650) | Emory University | 2005-05-01 |
| The Development and Testing of an Electronic Tool to Measure Physical Activity in Domestic Settings (NCT00207181) | Boston Medical Center | 2005-05-01 |
| CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) (NCT00219973) | Rovi Pharmaceuticals Laboratories | 2005-05-01 |
| Psychosocial Support for Cancer Patients (NCT00133965) | Memorial Sloan Kettering Cancer Center | 2005-05-01 |
| Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED) (NCT00112372) | Merck Sharp & Dohme LLC | 2005-05-01 |
| Strength and Nutrition Outcomes for Latino Adolescents (NCT00697580) | University of Southern California | 2005-05-01 |
| A VX-680 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Cancer (0457-002) (NCT02532868) | Merck Sharp & Dohme LLC | 2005-05-01 |
| CAFE Study - Cancer Patient Fracture Evaluation (NCT00211237) | Medtronic Spine LLC | 2005-05-01 |
| Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics (NCT00181012) | Gustave Roussy, Cancer Campus, Grand Paris | 2005-05-01 |
| Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma (NCT00110994) | Bayer | 2005-04-01 |